1. Home
  2. news

News

Featured
NewYorkBIO Responds to Proposed NIH Fu…
Read All About It

Latest News

NEWYORKBIO DELIVERS LETTER TO MAYOR MAMDANI URGING SUPPORT OF NYC’S LIFE SCIENCE INDUSTRY
More than 125 life science leaders and representatives from more than 65 companies joined the leading trade…
NewYorkBIO and Tesla Science Center at Wardenclyffe Embark on Strategic Collaboration
The relationship will support educational programs for all ages at the historic site
Introducing NewYorkBIO’s New Incubator & Accelerator Membership Tiers
We are excited to announce NewYorkBIO’s new Incubator & Accelerator Membership tiers, created to empower…
New York Bio Connect
In 2025, NewYorkBIO launched New York Bio Connect, a first-of-its-kind resource hub. Designed for…
Nilo Therapeutics Wins Inaugural NewYorkBIO Impact Award Presented by New York City Economic Development Corporation
The award celebrates innovation, economic impact, and leadership in New York City’s thriving life sciences…
NewYorkBIO, New York City Economic Development Corporation, & Empire State Development Partner to Launch New York Bio Connect
New York’s leading life science advocacy association and economic development organizations develop resource…
Statement on Behalf of Jennifer Hawks Bland on ORPHAN Cures Act
Statement on Behalf of Jennifer Hawks Bland, CEO of NewYorkBIO 
Show More News
RSS feeds source logo StatNews StatNews
FDA advisory panel narrowly rejects compounding of one peptide, backs two others
07/24/2026
Robert F. Kennedy Jr. has lauded peptides and said he takes them himself.
STAT+: Fatal gene-editing trial in China raises ethics and oversight questions
07/24/2026
Sanofi insulin pen in short supply, a win for peptide compounds, and more biotech news from The ...
STAT+: In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides
07/23/2026
The panel recommended allowing compounding pharmacies to produce popular but unproven BPC-157 and ...
FDA panel confronting peptide controversy
07/23/2026
Today's biotech news features the FDA weighing the fate of peptides; approvals for RevMed, GSK; and ...
STAT+: Pharma tries to tamp down broad China restrictions
07/22/2026
AI-focused VC firm raises $800M, Merck's new cholesterol pill, and more biotech news from The ...
STAT+: Rare disease drugmakers try to avoid Trump price cuts
07/21/2026
Plus, GOP voters want a crackdown on health care fraud, and how PBMs are skirting state laws.
STAT+: Broad Institute, partners unveil new initiative to develop gene therapies for rare diseases
07/21/2026
The Broad Institute, Boston Children’s Hospital, and Maine’s Jackson Laboratory announced a ...
STAT+: Anthropic deepens work with rare disease drugs
07/21/2026
Novo Nordisk sues Eli Lilly over GLP-1s, Medicare pricing plans, and more biotech news from The ...
STAT+: Makers of rare disease drugs seek exemption from Trump’s price-cut pilots
07/21/2026
A coalition of biotech firms is lobbying to exclude orphan drugs from new federal pilot programs ...